Landscape screening identifies the lactate-modifying enzyme AARS2 as a master regulator and therapeutic target in hepatocellular carcinoma

Authors:

Abstract
Background Hepatocellular carcinoma (HCC), one of the most prevalent cancers worldwide, has a high mortality owing to diagnostic challenges and therapeutic resistance. Lactate metabolism and protein lactylation play key roles in HCC progression; nevertheless, their regulatory mechanisms remain poorly understood. Objective This study aims to elucidate how lactate metabolism and protein lactylation contribute to HCC malignant progression by integrating multi-omics data, identifying key regulatory factors and exploring therapeutic strategies targeting this pathway. Design Integrated multi-omics analysis identified AARS2–AP-2γ as a key axis in HCC. Through mechanistic studies and virtual screening, we developed kukoamine A—a targeted inhibitor delivered via nanocarriers—demonstrating significant therapeutic potential. Results AARS2 was identified as a key regulator linking lactate metabolism to HCC progression through lactylation modification. It catalyses AP-2γ lactylation at K444, enhancing TRIM28 binding to promote K63-linked ubiquitination and nuclear translocation, thereby facilitating tumour progression. The inhibitor kukoamine A disrupts AARS2–AP-2γ interaction and, when delivered via zeolitic imidazolate framework-8 nanocarriers, demonstrates improved liver targeting, potent antitumour activity and synergy with PD-1 blockade, offering new strategic avenues for HCC precision therapy. Conclusion AARS2 links lactate metabolism to HCC progression via lactylation. Kukoamine A nanotherapy targeting this axis shows synergistic efficacy with immunotherapy, advancing the prospects of precision oncology.
Funding Information
  • The Key R&D Program of Jiangxi Province (20223BBG71008)
  • the Ganzhou Talent Project (GZSQZG202301010)
  • Jiangsu Provincial Medical Innovation Centre (CXZX202203)
  • the 111 Center (D17011)
  • the Zhanggong Science and Technology Plan Project (2023SF05)
  • the Ganzhou Science and Technology Project Young Talent Program (2022CXRC9712)
  • Jiangsu Province Hospital High-level Talent Cultivation Program (CZ0121002010037)
  • National Natural Science Foundation of China (82300684)
  • National Natural Science Foundation of China (82460122)
  • National Natural Science Foundation of China (82472862)
  • National Natural Science Foundation of China (82472938)
  • Jiangsu Provincial Medical Key Laboratory (ZDXYS202201)
  • Jiangsu Provincial Frontier Technology Research and Development Program (BF2024053)
  • Guangxi Key Reaserch and Development Program (GuikeAB25069034)
  • Natural Science Foundation of Jiangxi (20232ACB206006)
  • Natural Science Foundation of Jiangxi (20242BAB23074)

This publication has 44 references indexed in Scilit: